NCT04684823View on ClinicalTrials.gov

The Impact of Patch Rx Technologies on Adherence to Vitamin and Trikafta Therapies in Patients With Cystic Fibrosis

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

January 15, 2021

Primary Completion Date

December 27, 2021

Study Completion Date

December 27, 2021

Conditions
Cystic FibrosisAdherence, Medication
Interventions
DEVICE

Patch Cap

A prescription container cap to track the dispensing of an oral dose of medication with an associated app which tracks the adherence to medication regimen.

DEVICE

Patch App

A mobile app that is used with Patch Cap to track adherence to medication regimen

Trial Locations (1)

78229

The University of Texas Health Science Center at San Antonio, San Antonio

Sponsors

Collaborators (1)

Patch Rx Technologies
All Listed Sponsors
collaborator

Patch Rx Technologies

UNKNOWN

lead

The University of Texas Health Science Center at San Antonio

OTHER

NCT04684823 - The Impact of Patch Rx Technologies on Adherence to Vitamin and Trikafta Therapies in Patients With Cystic Fibrosis | Biotech Hunter | Biotech Hunter